KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Clorox (CLX) EBITDA (2016 - 2025)

Clorox (CLX) has 17 years of EBITDA data on record, last reported at $431.0 million in Q4 2025.

  • For Q4 2025, EBITDA rose 162.8% year-over-year to $431.0 million; the TTM value through Dec 2025 reached $1.5 billion, up 51.25%, while the annual FY2025 figure was $2.0 billion, 12.14% up from the prior year.
  • EBITDA reached $431.0 million in Q4 2025 per CLX's latest filing, up from $291.0 million in the prior quarter.
  • Across five years, EBITDA topped out at $596.0 million in Q2 2025 and bottomed at -$207.0 million in Q1 2023.
  • Average EBITDA over 5 years is $216.3 million, with a median of $180.0 million recorded in 2024.
  • Peak YoY movement for EBITDA: soared 615.38% in 2022, then tumbled 202.99% in 2023.
  • A 5-year view of EBITDA shows it stood at $65.0 million in 2021, then skyrocketed by 76.92% to $115.0 million in 2022, then soared by 100.87% to $231.0 million in 2023, then dropped by 29.0% to $164.0 million in 2024, then soared by 162.8% to $431.0 million in 2025.
  • Per Business Quant database, its latest 3 readings for EBITDA were $431.0 million in Q4 2025, $291.0 million in Q3 2025, and $596.0 million in Q2 2025.